CoChat

Lipid nanoparticles outperform electroporation in mRNA-based CAR T cell engineering

Kitte, Reni, Rabel, Martin, Geczy, Reka, Park, Stella, Fricke, Stephan, Koehl, Ulrike, Tretbar, U. Sandy · 2023 · Molecular Therapy Methods & Clinical Development
Cited by 125

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.omtm.2023.101139

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

7 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 37

  1. Watanabe, 2022, Impact of Manufacturing Procedures on CAR T Cell Functionality, Front. Immunol., 13, 10.3389/fimmu.2022.876339 · DOI · Paper page
  2. Melenhorst, 2022, Decade-long leukaemia remissions with persistence of CD4+ CAR T cells, Nature, 602, 503, 10.1038/s41586-021-04390-6 · DOI · Paper page
  3. Miliotou, 2018, CAR T-cell Therapy: A New Era in Cancer Immunotherapy, Curr. Pharmaceut. Biotechnol., 19, 5, 10.2174/1389201019666180418095526 · DOI · Paper page
  4. Wat, 2022, Hypogammaglobulinemia After Chimeric Antigen Receptor (CAR) T-Cell Therapy: Characteristics, Management, and Future Directions, J. Allergy Clin. Immunol. Pract., 10, 460, 10.1016/j.jaip.2021.10.037 · DOI
  5. Vora, 2020, Infectious Complications Following CD19 Chimeric Antigen Receptor T-cell Therapy for Children, Adolescents, and Young Adults, Open Forum Infect. Dis., 7, ofaa121, 10.1093/ofid/ofaa121 · DOI
  6. Irving, 2021, Choosing the Right Tool for Genetic Engineering: Clinical Lessons from Chimeric Antigen Receptor-T Cells, Hum. Gene Ther., 32, 1044, 10.1089/hum.2021.173 · DOI · Paper page
  7. Moretti, 2022, The Past, Present, and Future of Non-Viral CAR T Cells, Front. Immunol., 13, 867013, 10.3389/fimmu.2022.867013 · DOI
  8. Miliotou, 2020, In Vitro-Transcribed (IVT)-mRNA CAR Therapy Development, Methods Mol. Biol., 2086, 87, 10.1007/978-1-0716-0146-4_7 · DOI
  9. Soundara Rajan, 2020, In Vitro-Transcribed mRNA Chimeric Antigen Receptor T Cell (IVT mRNA CAR T) Therapy in Hematologic and Solid Tumor Management: A Preclinical Update, Int. J. Mol. Sci., 21, 6514, 10.3390/ijms21186514 · DOI · Paper page
  10. Beatty, 2014, Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce anti-tumor activity in solid malignancies, Cancer Immunol. Res., 2, 112, 10.1158/2326-6066.CIR-13-0170 · DOI · Paper page
  11. Beatty, 2018, Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 Trial, Gastroenterology, 155, 29, 10.1053/j.gastro.2018.03.029 · DOI · Paper page
  12. Cummins, 2017, Treating Relapsed/Refractory (RR) AML with Biodegradable Anti-CD123 CAR Modified T Cells, Blood, 130, 1359
  13. Tchou, 2017, Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer, Cancer Immunol. Res., 5, 1152, 10.1158/2326-6066.CIR-17-0189 · DOI · Paper page
  14. Svoboda, 2018, Nonviral RNA chimeric antigen receptor-modified T cells in patients with Hodgkin lymphoma, Blood, 132, 1022, 10.1182/blood-2018-03-837609 · DOI · Paper page
  15. Shah, 2023, Phase I Trial of Autologous RNA-electroporated cMET-directed CAR T cells Administered Intravenously in Patients with Melanoma & Breast Carcinoma, Cancer Res. Commun., 3, 821, 10.1158/2767-9764.CRC-22-0486 · DOI
  16. Shi, 2018, A Review on Electroporation-Based Intracellular Delivery, Molecules, 23, 3044, 10.3390/molecules23113044 · DOI · Paper page
  17. DiTommaso, 2018, Cell engineering with microfluidic squeezing preserves functionality of primary immune cells in vivo, Proc. Natl. Acad. Sci. USA, 115, E10907, 10.1073/pnas.1809671115 · DOI · Paper page
  18. Xin, 2022, In-Vivo Induced CAR-T Cell for the Potential Breakthrough to Overcome the Barriers of Current CAR-T Cell Therapy, Front. Oncol., 12, 10.3389/fonc.2022.809754 · DOI · Paper page
  19. Parayath, 2020, In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo, Nat. Commun., 11, 6080, 10.1038/s41467-020-19486-2 · DOI · Paper page
  20. Ye, 2022, Research advance in lipid nanoparticle-mRNA delivery system and its application in CAR-T cell therapy. Zhejiang da xue xue bao, Medical sciences, 51, 185
  21. Kitchen, 2004, CD4 on CD8(+) T cells directly enhances effector function and is a target for HIV infection, Proc. Natl. Acad. Sci. USA, 101, 8727, 10.1073/pnas.0401500101 · DOI
  22. Moradian, 2022, Chemical modification of uridine modulates mRNA-mediated proinflammatory and antiviral response in primary human macrophages. Molecular therapy, Nucleic acids, 27, 854, 10.1016/j.omtn.2022.01.004 · DOI · Paper page
  23. Parr, 2020, N 1-Methylpseudouridine substitution enhances the performance of synthetic mRNA switches in cells, Nucleic Acids Res., 48, e35, 10.1093/nar/gkaa070 · DOI · Paper page
  24. Billingsley, 2022, Orthogonal Design of Experiments for Optimization of Lipid Nanoparticles for mRNA Engineering of CAR T Cells, Nano Lett., 22, 533, 10.1021/acs.nanolett.1c02503 · DOI · Paper page
  25. Billingsley, 2020, Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering, Nano Lett., 20, 1578, 10.1021/acs.nanolett.9b04246 · DOI · Paper page
  26. Tanaka, 2021, Improvement of mRNA Delivery Efficiency to a T Cell Line by Modulating PEG-Lipid Content and Phospholipid Components of Lipid Nanoparticles, Pharmaceutics, 13, 2097, 10.3390/pharmaceutics13122097 · DOI
  27. Birkholz, 2009, Transfer of mRNA encoding recombinant immunoreceptors reprograms CD4+ and CD8+ T cells for use in the adoptive immunotherapy of cancer, Gene Ther., 16, 596, 10.1038/gt.2008.189 · DOI
  28. von Auw, 2023, U.S. Comparison of two lab-scale protocols for enhanced mRNA-based CAR-T cell generation and functionality, Sci. Rep., 13, 18160, 10.1038/s41598-023-45197-x · DOI
  29. Inoo, 2016, Immunological quality and performance of tumor vessel-targeting CAR-T cells prepared by mRNA-EP for clinical research, Mol. Ther. Oncolytics, 3, 10.1038/mto.2016.24 · DOI
  30. Harris, 2021, Optimization of electroporation and other non-viral gene delivery strategies for T cells, Biotechnol. Prog., 37, 10.1002/btpr.3066 · DOI
  31. Campillo-Davo, 2021, The Ins and Outs of Messenger RNA Electroporation for Physical Gene Delivery in Immune Cell-Based Therapy, Pharmaceutics, 13, 396, 10.3390/pharmaceutics13030396 · DOI
  32. Paramasivam, 2022, Endosomal escape of delivered mRNA from endosomal recycling tubules visualized at the nanoscale, J. Cell Biol., 221, 10.1083/jcb.202110137 · DOI · Paper page
  33. Thomas, 2018, Microfluidic Production and Application of Lipid Nanoparticles for Nucleic Acid Transfection, Methods Mol. Biol., 1792, 193, 10.1007/978-1-4939-7865-6_14 · DOI
  34. Paunovska, 2022, The Extent to Which Lipid Nanoparticles Require Apolipoprotein E and Low-Density Lipoprotein Receptor for Delivery Changes with Ionizable Lipid Structure, Nano Lett., 22, 10025, 10.1021/acs.nanolett.2c03741 · DOI
  35. Zhang, 2021, Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver, Biomater. Sci., 9, 1449, 10.1039/D0BM01609H · DOI · Paper page
  36. Gomes-Silva, 2017, Tonic 4-1BB Costimulation in Chimeric Antigen Receptors Impedes T Cell Survival and Is Vector-Dependent, Cell Rep., 21, 17, 10.1016/j.celrep.2017.09.015 · DOI · Paper page
  37. Webb, 2022, Current Status and Future Perspectives on MRNA Drug Manufacturing, Mol. Pharm., 19, 1047, 10.1021/acs.molpharmaceut.2c00010 · DOI

Cited by

See all 125

Metadata

Authors
Kitte, R., Rabel, M., Geczy, R., Park, S., Fricke, S., Koehl, U., & Tretbar, U. S.
Venue
Molecular Therapy Methods & Clinical Development
Publisher
Elsevier BV
Published
2023-12
Volume
31
Pages
101139
ISSN
2329-0501
Cited by
125
References
11
Language
en
Licence
Funders
Bundesministerium für Bildung und Forschung (16GW0322)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lipid nanoparticles outperform electroporation in mRNA-based CAR T cell engineering. https://app.cochat.ai/papers/10.1016/j.omtm.2023.101139
The paper
Kitte, R., Rabel, M., Geczy, R., Park, S., Fricke, S., Koehl, U., & Tretbar, U. S. (2023). Lipid nanoparticles outperform electroporation in mRNA-based CAR T cell engineering. Molecular Therapy Methods & Clinical Development. https://doi.org/10.1016/j.omtm.2023.101139

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.